| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316616 | Pancreatology | 2013 | 7 Pages |
Abstract
The present study demonstrated that miR-181b was associated with the resistance of pancreatic cancer cells to gemcitabine, and verified that miR-181b enhances the activity of NF-κB by inhibiting CYLD, leading to the resistance to gemcitabine. Our results suggest that miR-181b is a potential target for decreasing gemcitabine resistance.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Daisuke Takiuchi, Hidetoshi Eguchi, Hiroaki Nagano, Yoshifumi Iwagami, Yoshito Tomimaru, Hiroshi Wada, Koichi Kawamoto, Shogo Kobayashi, Shigeru Marubashi, Masahiro Tanemura, Masaki Mori, Yuichiro Doki,